Related Experiment Video
Updated: Aug 10, 2026
06:39
Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
The coronary artery surgery study (CASS)--a randomized trial and a registry
Zeitschrift Fur Kardiologie
|January 1, 1985
Summary
The Coronary Artery Surgery Study (CASS) and similar trials show coronary artery bypass surgery improves survival for high-risk patients. Surgery can be delayed for low-risk patients, with graft patency a key consideration.
Area of Science:
- Cardiology
- Clinical Trials
- Cardiovascular Surgery
Background:
- The National Heart, Lung, and Blood Institute established the Coronary Artery Surgery Study (CASS) in 1973.
- CASS comprised a patient registry and a randomized trial comparing medical and surgical treatments for coronary artery disease.
Purpose of the Study:
- To compare the efficacy of medical versus surgical therapy for patients diagnosed with coronary artery disease.
- To analyze findings in conjunction with other major randomized trials on coronary artery bypass surgery.
Main Methods:
- Detailed discussion and comparative analysis of the CASS trial.
- Comparison with the US Veterans Administration Trial (VA) and the European Cooperative Surgical Study (ECSS).
- Evaluation of patient outcomes, including survival rates, myocardial infarction incidence, and graft patency.
Main Results:
- Identified specific high-risk patient groups who benefit from improved survival with surgical intervention.
- Demonstrated the protective effect of surgery against myocardial infarction in certain patient cohorts.
- Observed graft patency deterioration over time, influencing long-term outcomes.
- Indicated that surgery could be postponed for patients deemed low-risk.
Conclusions:
- Despite methodological differences, CASS, VA, and ECSS trials offer comparable insights.
- Coronary artery bypass surgery offers survival benefits for select high-risk individuals.
- Medical management may be a suitable alternative for low-risk patients, deferring surgery.
- Graft patency is a critical factor in the long-term success of coronary artery bypass surgery.
More Related Videos
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...